What is Schering-Plough's R&D?

Schering-Plough (SGP) reported R&D of $8.54M in Q1 2026.

How has Schering-Plough's R&D changed year-over-year?

Schering-Plough's R&D increased by 41.1% year-over-year, from $6.05M to $8.54M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Schering-Plough SGP R&D

R&D at other companies

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

GlaukosGKOS

$44.15M+36.4%

Bausch + LombBLCO

$101M+17.4%

HRO

HarrowHROW

$5.9M+94.8%

EyePoint, Inc. EYPT

$72.15M+23.2%

Ocular TherapeutixOCUL

$66.21M+54.5%

Other financials

Income statement

See full

Operating income-$15.4M-108%

Net income-$13.8M-56.6%

EPS (diluted)-$0.69+82.6%

Balance sheet

See full

Cash & equivalents$238.9M+312%

Total debt$1.6M—

Total equity$250.1M+463%

Total assets$258.4M—

Cash flow

See full

Operating cash flow-$13.5M-65.2%

CapEx$676.0K+312%

Free cash flow-$14.2M-70.0%

Valuation

See full

Market cap$744.23M-23.4%

Enterprise value$506.93M—

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×—

Current ratio38×—

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Schering-Plough's R&D?: Schering-Plough (SGP) reported R&D of $8.54M in Q1 2026.
How has Schering-Plough's R&D changed year-over-year?: Schering-Plough's R&D increased by 41.1% year-over-year, from $6.05M to $8.54M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.